Pfizer Inc. (BVMF:PFIZ34)

Market Cap	807.80B -8.9%
Revenue (ttm)	344.69B -1.6%
Net Income	42.80B -3.2%
EPS	7.51 -3.4%
Shares Out	n/a
PE Ratio	18.87
Forward PE	9.17
Dividend	1.58 (4.49%)
Ex-Dividend Date	Jan 22, 2026

Volume	10,967
Average Volume	15,728
Open	34.60
Previous Close	34.82
Day's Range	34.49 - 35.65
52-Week Range	30.84 - 39.40
Beta	0.44
RSI	55.86
Earnings Date	Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: PFIZ34

Financial Performance

In 2025, Pfizer's revenue was $62.58 billion, a decrease of -1.65% compared to the previous year's $63.63 billion. Earnings were $7.77 billion, a decrease of -3.24%.

Financial numbers in USD